A Additional parameterisation of within and across trial interactions
The random treatment effect model with random trial-level treatment-covariate interaction and random trial-level effect of the patient-level covariate, z i j , which separates the within and across trial interactions is:
where z i j is the covariate value for patient i in trial j with coefficient α j for trial j andz j is the mean value of z i j for trial j. In this model β 1 j , . . . , β q j are random treatment effects. The within trial interaction is estimated by µ δ A whilst the across trial information is estimated by µ δ A + µ δ B .
The random treatment effect model with random trial-level treatment-covariate interaction and random trial-level effect of the patient-level covariate, z i j , which combines the within and across trial interactions is:
where z i j is the covariate value for patient i in trial j with coefficient α j for trial j, β 1 j , . . . , β q j are random treatment effects and δ 1 j , . . . , δ q j are random treatment-covariate interaction effects.
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